US Patent Issued to CONNECT BIOPHARMA HONGKONG on April 14 for "Antibody for binding to interleukin 4 receptor" (Chinese, Canadian, American Inventors)

Posted On: 2026-04-15

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,771, issued on April 14, was assigned to CONNECT BIOPHARMA HONGKONG Ltd. (Kowloon, Hong Kong). "Antibody for binding to interleukin 4 rece... Read More

US Patent Issued to Motokazu Kato on April 14 for "Therapeutic agent for asthma containing IL-6 inhibitor" (Japanese Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,772, issued on April 14, was assigned to Motokazu Kato (Osaka, Japan). "Therapeutic agent for asthma containing IL-6 inhibitor" was invent... Read More

US Patent Issued to Novo Nordisk, Yale University on April 14 for "Treatment of diuretic resistant heart failure patients having at least one copy of the TMPRSS6 rs855791 allele" (Connecticut, Maryland, Massachusetts Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,773, issued on April 14, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark) and Yale University (New Haven, Conn.). "Treatment of diure... Read More

US Patent Issued to Shijiazhuang Yiling Pharmaceutical on April 14 for "Monoclonal antibodies against CLDN18.2 and Fc-engineered versions thereof" (Chinese Inventor)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,774, issued on April 14, was assigned to Shijiazhuang Yiling Pharmaceutical Co. Ltd. (Shijiazhuang, China). "Monoclonal antibodies against... Read More

US Patent Issued to Kite Pharma on April 14 for "Chimeric antigen receptor T cell therapy" (California Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,775, issued on April 14, was assigned to Kite Pharma Inc. (Santa Monica, Calif.). "Chimeric antigen receptor T cell therapy" was invented ... Read More

US Patent Issued to CARTEXELL on April 14 for "Anti-L1CAM antibody or antigen-binding fragment thereof and chimeric antigen receptor comprising same" (South Korean Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,776, issued on April 14, was assigned to CARTEXELL INC. (Seoul, South Korea). "Anti-L1CAM antibody or antigen-binding fragment thereof and... Read More

US Patent Issued to Novartis, Immutep on April 14 for "Combination therapies comprising antibody molecules to LAG-3" (American, French Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,777, issued on April 14, was assigned to Novartis AG (Basel, Switzerland) and Immutep S.A.S. (Orsay, France). "Combination therapies compr... Read More

US Patent Issued to The Research Foundation for The State University of New York, The Regents of the University of California on April 14 for "Rage antibodies, fragments and uses thereof" (New York, California Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,778, issued on April 14, was assigned to The Research Foundation for The State University of New York (Amherst, N.Y.) and The Regents of th... Read More

US Patent Issued to MACROGENICS on April 14 for "LAG-3-binding molecules and methods of use thereof" (Maryland, California Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,779, issued on April 14, was assigned to MACROGENICS INC. (Rockville, Md.). "LAG-3-binding molecules and methods of use thereof" was inven... Read More

US Patent Issued to Regeneron Pharmaceuticals on April 14 for "Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof" (New York Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,780, issued on April 14, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Anti-CD3 antibodies, bispecific antigen-bindin... Read More

Exclusive

Category

Source

Publication

Byline

Location

US Patent Issued to CONNECT BIOPHARMA HONGKONG on April 14 for "Antibody for binding to interleukin 4 receptor" (Chinese, Canadian, American Inventors)

US Patent Issued to Motokazu Kato on April 14 for "Therapeutic agent for asthma containing IL-6 inhibitor" (Japanese Inventors)

US Patent Issued to Novo Nordisk, Yale University on April 14 for "Treatment of diuretic resistant heart failure patients having at least one copy of the TMPRSS6 rs855791 allele" (Connecticut, Maryland, Massachusetts Inventors)

US Patent Issued to Shijiazhuang Yiling Pharmaceutical on April 14 for "Monoclonal antibodies against CLDN18.2 and Fc-engineered versions thereof" (Chinese Inventor)

US Patent Issued to Kite Pharma on April 14 for "Chimeric antigen receptor T cell therapy" (California Inventors)

US Patent Issued to CARTEXELL on April 14 for "Anti-L1CAM antibody or antigen-binding fragment thereof and chimeric antigen receptor comprising same" (South Korean Inventors)

US Patent Issued to Novartis, Immutep on April 14 for "Combination therapies comprising antibody molecules to LAG-3" (American, French Inventors)

US Patent Issued to The Research Foundation for The State University of New York, The Regents of the University of California on April 14 for "Rage antibodies, fragments and uses thereof" (New York, California Inventors)

US Patent Issued to MACROGENICS on April 14 for "LAG-3-binding molecules and methods of use thereof" (Maryland, California Inventors)

US Patent Issued to Regeneron Pharmaceuticals on April 14 for "Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof" (New York Inventors)